

| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | -8.9% | -41.3% |
| Cost of Revenue | $123K | -28.1% | -66.9% |
| Gross Profit | $991K | -5.8% | -35.0% |
| R&D Expense | $1.5M | -32.7% | -5.0% |
| SG&A Expense | $2.2M | +32.7% | -1.7% |
| Operating Income | -$3.8M | +7.0% | -3.8% |
| Interest Expense | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.1M | +4.8% | — |
| Accounts Receivable | $94K | -88.5% | — |
| Current Assets | $6.0M | -3.7% | — |
| Total Assets | $28.5M | -3.5% | — |
| Current Liabilities | $6.7M | -12.2% | — |
| Total Liabilities | $13.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.8M | — | — |
| Capital Expenditures | $21K | — | — |
| Investing Cash Flow | -$21K | — | — |
| Financing Cash Flow | $7.0M | — | — |
| Free Cash Flow | -$6.8M | — | — |
| -100.0% |
| Pre-tax Income | -$3.2M | -0.6% | +43.4% |
| Income Tax | $1K | +0.0% | +100.7% |
| Net Income | -$3.2M | -0.6% | +41.9% |
| -12.8% |
| — |
| Stockholders' Equity | $15.2M | +6.5% | +11.7% |